| http://www.w3.org/ns/prov#value | - SIGA hopes to market the capsule internationally as well.SIGA's groundbreaking drug, ST-246, is an oral therapeutic agent active against orthopoxviruses including smallpox.It is the only drug from any source ever to have demonstrated efficacy in non-human primate models of orthopox virus disease, which was a requirement of the request for proposal that resulted in the current contract.ST-246 will
|
